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AbstrAct
Introduction Post-traumatic stress disorder (PTSD) is being 
increasingly reported among survivors of critical illness and 
injury. Previous work has demonstrated that PTSD reduces 
patient quality of life and ability to return to work, as well as 
increases healthcare costs. As such, identifying interventions 
aimed at preventing the development of critical illness-related 
PTSD could have an important public health impact. The 
objective of this systematic review is to collate the world’s 
literature on early interventions aimed at preventing PTSD 
among survivors of critical illness.
Methods and analysis We will perform a qualitative 
systematic review of human clinical trials of interventions 
aimed at preventing or reducing critical illness-related PTSD 
symptoms. We will methodically search CENTRAL, MEDLINE, 
Embase and CINAHL. We will also search websites containing 
details on clinical trials registration (National Library of 
Medicine’s  ClinicalTrials. gov and the WHO’s International 
Clinical Trials Registry Platform), as well as screen reference 
lists of the articles we select for inclusion to identify additional 
studies for potential inclusion. Two authors will independently 
review all search results. After identification and inclusion of 
articles, we will use a standardised form for data extraction. 
We will use tables to describe the study type, populations, 
interventions tested and timing of interventions, outcome 
measures and effects of interventions on outcome measures 
compared with control groups. This review will be completed 
between 1 August 2017 and 31 August 2017.
Ethics and dissemination The proposed systematic review 
will not collect individual patient level data and does not 
require ethical approval. Results of this study will contribute 
to the understanding of critical illness-related PTSD and 
help prompt future research aimed at further developing 
interventions to prevent PTSD symptoms in survivors of 
critical illness.
PrOsPErO registration number This systematic review 
is registered in the PROSPERO international prospective 
register of systematic reviews (registration number 
CRD42017069672).
IntrOductIOn
Post-traumatic stress disorder (PTSD) is being 
increasingly reported among survivors of crit-
ical illness. It is currently estimated that 25% 
of critical illness survivors suffer from PTSD,1 
with the incidence among certain popula-
tions approaching 65%.2 PTSD is defined as 
the development of mental health concerns 
in someone who is directly or indirectly 
exposed to a traumatic event. More specifi-
cally, trauma is operationalised as someone 
who is exposed to death, threatened death, 
actual or threatened serious injury, or actual 
or threatened sexual violence. Subsequently, 
the individual develops symptoms from each 
of four symptom clusters: intrusive thoughts 
or memories, avoidance of trauma-related 
stimuli, negative alterations in cognitions and 
mood and alterations in arousal and reactivity.3 
Critical illness is by definition a life-threat-
ening experience, which predisposes many 
patients to these chronic psychological symp-
toms. Previous work has demonstrated that 
patients suffering from PTSD are more likely 
to have poor physical health-related quality 
of life with higher frequency and severity of 
general health symptoms and conditions, 
such as musculoskeletal pain, cardiorespi-
ratory symptoms and gastrointestinal symp-
toms.4 Furthermore, PTSD is independently 
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Protocol
strengths and limitations of this study
 ► This systematic review will be the first comprehensive 
search of the literature to identify and describe early 
interventions aimed at preventing intensive care 
unit-related (ICU) post-traumatic stress disorder.
 ► Experts in the field, including a clinical psychologist 
and intensivists, with experience performing 
systematic reviews, developed our search strategy.
 ► We plan to perform an exhaustive search of multiple 
databases (ie, CENTRAL, MEDLINE, Embase and 
CINAHL).
 ► It is highly likely that we will find a paucity of data on 
early interventions aimed at preventing ICU-related 
post-traumatic stress disorder.
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associated with the inability to return to work 12 months 
after intensive care unit (ICU) discharge,5 as well as 
increased healthcare costs.6 As such, preventing the 
development of PTSD could have an enormous influence 
on long-term patient outcomes as well as public health.
The development of critical illness-related PTSD has 
been linked to patient experience during medical care. 
Specifically, frightening experiences7 and acute psycho-
logical stress during resuscitation care are strongly associ-
ated with the development of PTSD.8 A central mechanism 
to the development of PTSD is the process by which trau-
matic memories are formed.9 For many patients, fright-
ening experiences result in peritraumatic dissociation, 
defined as an alteration in time or place with reported 
feelings of depersonalisation, altered perceptions of pain, 
feeling disconnected or tunnel vision.10 This dissociation 
has been demonstrated to increase the risk for devel-
oping PTSD,10 likely by causing traumatic information 
to be encoded in somatosensory, affective, non-linguistic 
and relatively uncontrolled fragmented memories.11 Our 
overarching hypothesis is that interventions, which focus 
on decreasing the degree of acute stress (ie, frightening 
experiences) and dissociation during the traumatic event 
in the hospital, will shift traumatic information processing 
from developing uncontrollable fragmented memory to 
a more controllable and cognitive memory process, and 
thus prevent or reduce PTSD severity in survivors of crit-
ical illness.
The first step towards testing this hypothesis is to 
collate the world’s literature on interventions aimed at 
preventing or reducing PTSD symptoms in patients who 
survive medical emergencies. We hypothesise that there 
are currently few or no interventions aimed at reducing 
the degree of acute stress and dissociation, during the 
traumatic event in the hospital, in order to prevent 
chronic PTSD in this population.
MEthOds And AnAlysIs
Protocol and registration
This systematic review protocol is prepared in accordance 
with the Cochrane handbook for systematic reviews 
of interventions12 and the Preferred Reporting Items 
for Systematic Reviews and Meta-Analysis (PRISMA) 
Protocols statement.13 The final results will be reported 
according to PRISMA and the Meta-analysis of Obser-
vational Studies in Epidemiology guidelines.14 15 This 
systematic review has been registered in the PROSPERO 
international prospective register of systematic reviews 
(registration number CRD42017069672).
search for and identification of studies
An electronic search will include the following databases: 
CENTRAL, MEDLINE, Embase and CINAHL. The search 
terms include the concepts of post-traumatic stress, crit-
ical care and prevention. These strategies were developed 
by a group of experts, including a clinical psychologist 
and intensivists with experience performing systematic 
reviews. We used a combination of standardised terms 
and keywords and modelled the search after a previously 
published systematic review examining the prevalence 
of ICU-related PTSD.2 The fully reproducible search 
strategy is provided in the online supplementary. In order 
to identify potentially unpublished data from clinical 
trials, we will search websites containing details on clinical 
trials registration (National Library of Medicine’s  Clini-
calTrials. gov and the WHO’s International Clinical Trials 
Registry Platform). Registered but unpublished trials will 
be considered eligible for inclusion if the registration 
website indicates that enrolment in the clinical trial had 
been completed. We will also screen reference lists of 
the articles we select for inclusion to identify additional 
studies for potential inclusion.
Eligibility criteria
We will include all human prospective interventional trials 
to prevent PTSD in the critically ill and injured. In order 
to be included, all studies must contain1 adult patients 
diagnosed with a critical illness or injury2; patients treated 
in an emergency department or ICU setting3; an interven-
tion arm in which subjects clearly underwent an interven-
tion aimed at preventing or reducing PTSD symptoms, as 
the single experimental intervention4; a clearly defined 
control arm in which subjects received placebo or stan-
dard of care therapy;5 and an outcome measure assessing 
development of acute stress or PTSD symptoms. We will 
consider studies eligible for review regardless of language 
or publication type. We will exclude studies that are 
secondary reports of previously published trials. We also 
will exclude papers that are reviews, correspondence or 
editorials; however, we will screen the reference lists of 
review articles to identify further studies for inclusion.
study selection and data abstraction
Two independent reviewers will screen the titles and 
abstracts of identified studies for potential eligibility. After 
the relevance screen, the two reviewers will compare their 
exclusion logs to determine whether there is disagree-
ment and use the Kappa statistic to quantify the interob-
server agreement. In cases of disagreement, the full text 
will be reviewed for inclusion. All studies deemed poten-
tially relevant will be obtained, and the full manuscripts 
will be reviewed for inclusion. Two reviewers will inde-
pendently abstract data on study types, patient popula-
tions, interventions and timing of interventions, outcome 
measures, adverse events and results using a standardised 
data collection form. This review will be completed 
between 1 August 2017 and 31 August 2017.
Assessment of study bias
For each randomised clinical trial, we will assess the 
quality of the studies selected for inclusion using the 
Cochrane Collaboration’s tool for assessing the risk of 
bias in clinical trials evaluating six domains (selection, 
performance, detection, attrition, reporting and other 
biases).12 For each non-randomised clinical trial, we will 
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assess the quality of the studies selected using the Newcas-
tle-Ottawa Quality Assessment Scale, as recommended in 
the Cochrane Handbook.12
Analysis
We will perform a primarily qualitative analysis of the 
data in accordance with the recommended methodology 
for qualitative reviews published in the Cochrane Hand-
book.12 We will collate and summarise clinical trials in 
table format, stratified by individual publication. We will 
include in the table1: study type,2 population sampled (eg, 
motor vehicle crash and patients with sepsis),3 descrip-
tion of intervention performed,4 timing of intervention,5 
outcome measures, including primary and all secondary 
outcomes,6 and effect of intervention on outcome 
measures compared with control groups.
Given the likely heterogeneity in both interventions 
and outcome measures, it is unlikely that it will be 
possible to pool data. However, if after conducting the 
systematic review it is determined data can be pooled, we 
will perform meta-analyses using random effects models 
to calculate overall effect sizes and 95% CIs between 
intervention and control groups. For binary data, such as 
development of PTSD (yes/no), ORs will be calculated, 
and for continuous outcomes, mean differences will be 
reported. A p value of <0.05 will be considered statis-
tically significant. Finally, the I2 statistic will be used to 
assess heterogeneity between studies. We will consider the 
following thresholds for the I2 statistic: low (25%–49%), 
moderate (50%–74%) and high (≥75%) values.16
Protocol amendments
If an amendment to this protocol is required, the date of 
each amendment will be accompanied by a description of 
the change along with the rationale.
Ethics and dissemination
No ethical approval will be required for this systematic 
review of completed studies. Results from this system-
atic review will be submitted to peer-reviewed journals 
for publication and to national meetings in presentation 
form. We anticipate that this study will identify a need for 
further research aimed at developing early interventions 
to prevent or reduce PTSD symptoms in survivors of crit-
ical illness.
dIscussIOn
There has been an increasing understanding that 
emotional trauma in the form of PTSD is common 
among patients who experience serious health emergen-
cies and survive critical illness. PTSD has been shown to 
have long-lasting effects on physical and emotional well-
being,4 along with increasing healthcare costs.6 However, 
it is currently unclear if early interventions can prevent 
or reduce emotional trauma in patients suffering from 
health emergencies.
This systematic review will collate the world’s literature 
of early interventions aimed at preventing the develop-
ment of PTSD in survivors of critical illness. We expect 
to find that there are currently few or no interventions 
aimed at reducing the degree of acute stress and disso-
ciation, during the traumatic event in the hospital, in 
order to prevent chronic PTSD in this population. Specif-
ically, we will identify important knowledge gaps in the 
literature.
The results of this study will contribute to the under-
standing of critical illness-related PTSD and help prompt 
future research aimed at further developing interventions 
to prevent PTSD symptoms in survivors of critical illness.
contributors All authors have made substantial contributions to this paper. BWR 
supervised all aspects of the study design and takes responsibility for the paper 
as a whole. All authors contributed to the development of the selection criteria, the 
risk of bias assessment strategy and data extraction criteria. MBR, ST and BWR 
developed the search strategy. BWR provided statistical expertise. LJG and BWR 
drafted the manuscript. All authors read and contributed substantially to revision of 
the final manuscript and approved the manuscript in its final form.
Funding This research received no specific grant from any funding agency in the 
public, commercial or not-for-profit sector. 
competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Open Access This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited and the use is non-commercial. See: http:// creativecommons. org/ 
licenses/ by- nc/ 4. 0/
© Article author(s) (or their employer(s) unless otherwise stated in the text of the 
article) 2017. All rights reserved. No commercial use is permitted unless otherwise 
expressly granted.
rEFErEncEs
 1. Wade D, Hardy R, Howell D, et al. Identifying clinical and acute 
psychological risk factors for PTSD after critical care: a systematic 
review. Minerva Anestesiol 2013;79:944–63.
 2. Griffiths J, Fortune G, Barber V, et al. The prevalence of post 
traumatic stress disorder in survivors of ICU treatment: a systematic 
review. Intensive Care Med 2007;33:1506–18.
 3. American Psychiatric Association. Diagnostic and statistical manual. 
5th ed (DMS-5). Washington, D.C: American Psychiatric Association, 
2013.
 4. Pacella ML, Hruska B, Delahanty DL. The physical health 
consequences of PTSD and PTSD symptoms: a meta-analytic 
review. J Anxiety Disord 2013;27:33–46.
 5. Zatzick D, Jurkovich GJ, Rivara FP, et al. A national US study of 
posttraumatic stress disorder, depression, and work and functional 
outcomes after hospitalization for traumatic injury. Ann Surg 
2008;248:79–87.
 6. Walker EA, Katon W, Russo J, et al. Health care costs associated 
with posttraumatic stress disorder symptoms in women. Arch Gen 
Psychiatry 2003;60:369–74.
 7. Elliott R, McKinley S, Fien M, et al. Posttraumatic stress symptoms in 
intensive care patients: an exploration of associated factors. Rehabil 
Psychol 2016;61:141–50.
 8. Davydow DS, Zatzick D, Hough CL, et al. A longitudinal investigation 
of posttraumatic stress and depressive symptoms over the course 
of the year following medical-surgical intensive care unit admission. 
Gen Hosp Psychiatry 2013;35:226–32.
 9. van der Kolk BA, Fisler R. Dissociation and the fragmentary nature 
of traumatic memories: overview and exploratory study. J Trauma 
Stress 1995;8:505–25.
 10. McCanlies EC, Sarkisian K, Andrew ME, et al. Association of 
peritraumatic dissociation with symptoms of depression and 
posttraumatic stress disorder. Psychol Trauma 2017;9:479–84.
 on 24 S
eptem









pen: first published as 10.1136/bm






4 Glaspey LJ, et al. BMJ Open 2017;7:e018270. doi:10.1136/bmjopen-2017-018270
Open Access 
 11. Gidron Y, Gal R, Freedman S, et al. Translating research findings to 
PTSD prevention: results of a randomized-controlled pilot study. J 
Trauma Stress 2001;14:773–80.
 12. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews 
of Interventions Version 5.1.0. The Cochrane Collaboration. 2011. 
http://www. cochrane- handbook. org
 13. Shamseer L, Moher D, Clarke M, et al. Preferred reporting items for 
systematic review and meta-analysis protocols (PRISMA-P) 2015: 
elaboration and explanation. BMJ 2015;349:g7647.
 14. Foy R. Preferred reporting items for systematic reviews and meta-
analyses: the PRISMA statement. Annals of Internal Medicine 
2010;151:264–9.
 15. Stroup D, Berlin J, Morton S, et al. Meta-analysis of observational 
studies in epidemiology: a proposal for reporting. JAMA 
2000;283:2010–2.
 16. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-
analysis. Stat Med 2002;21:1539–58.
 on 24 S
eptem









pen: first published as 10.1136/bm
jopen-2017-018270 on 1 S
eptem
ber 2017. D
ow
nloaded from
 
